A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19833819

Download in:

View as

General Info

PMID
19833819